Behavioral & Integrative Treatment Development Program (R03)
Grant Amounts: The National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the Office of Behavioral and Social Sciences (OBSSR) are providing $100,000 for this funding opportunity. They are seeking research grant applications on the development and testing of behavioral and integrative treatments for drug and alcohol abuse and dependence. The purpose of this FOA for R03s is to encourage investigators to propose discrete well-defined projects that can be completed within two years. Projects of interest fall within the research domain of behavioral or integrated (e.g., behavioral and pharmacological) interventions targeting: (a) drug abuse (including comorbidities); (b) prevention of acquisition or transmission of HIV infection among individuals in drug abuse treatment; (c) promotion of adherence to drug abuse treatment, HIV and addiction medications; and (d) chronic pain. Specific examples include, but are not limited to studies focusing on: (1) Stage I intervention generation; (2) Stage I pilot or feasibility and both should include the development of putative moderators, mediators, and change mechanisms; (3) Stage I studies to generate or refine drug abuse treatment or adherence interventions for use in primary care; (4) Stage I research to boost effects and increase implementability of interventions with creative use of technology or through other means. Companion funding opportunites are: PA-13-078, R34 Clinical Trial Planning Grant Program and PA-13-077, R01 Research Project Grant
National Institute on Drug Abuse US Department of Health and Human Services Public Health Service National Institutes of Health National Institute on Alcohol Abuse and Alcoholism
City Agencies Colleges/Universities Commercial Organizations County Agencies Federal Government Agencies IRS 501 (c)(3) Organizations Nonprofit Organizations Public Health Departments/Social Services Departments Religious Organizations Schools State Agencies Tribal Organizations
Lisa Onken, Ph.D. Chief, Behav & Integ Treatment Branch Assoc Dir for TreatmentDiv of Clin Neur & Behav Rsch NIH, NIDA 6001 Executive Blvd Room 3172 MSC 9593 Bethesda, MD 208929593 Phone: (301) 443-2235
Behavioral Research Drug Abuse HIV/AIDS Prevention Primary Care Research Programs Substance Abuse Treatment and Counseling
Health Professionals Physicians Researchers
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
For information on Application Submission and Receipt, visit Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications.
Required and Optional Components The forms package associated with this FOA includes all applicable components, mandatory and optional. Please note that some components marked optional in the application package are required for submission of applications for this FOA. Follow all instructions in the SF424 (R&R) Application Guide to ensure you complete all appropriate “optional” components.
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.